Rating History for SAB Biotherapeutics (SABS) by Argus
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/7/2026 | N/A | New Coverage | Buy (N/A) |
7.00 (N/A) |
3.62 (3.79) |
4.7% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/7/2026 | N/A | New Coverage | Buy (N/A) |
7.00 (N/A) |
3.62 (3.79) |
4.7% | Details |